Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Editing
Adjuvant therapy for DTC
(section)
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== '''Radioiodine ablation''' == * Tumour type and operation ** Useful with PTC and FTC ** Commonly given with HCC too, although not as effective ** Not given for PDTC, MTC and ATC ** Obviously contraindicated if only hemithyroidectomy was performed * Risk profile ** Low-risk: not routinely given ** Intermediate risk: selective but usually give at lower dose like 30mCi (microscopic or vascular invasion, significant lymph node metastases, aggressive histology) ** High-risk: give, usually at a higher dose like 100mCi * Indications ** Ablate residual normal thyroid tissue (increase specificity of serum Tg for surveillance; prevent subsequent de novo cancer; treat microscopic disease) ** Treat clinically detectable disease not addressed by surgery * Protocol ** Should be administered in a low-iodine state and high TSH levels, to maximise RAI uptake by thyroid tissue ** Patient needs to be in isolation for 24-48 hours ** Improves disease-free survival via ablation of residual or metastatic disease ** Remnant ablation dose - 30-50mCi ** Treatment dose - 100-150mCi ** Pregnancy and breastfeeding are absolute contraindications; don't become pregnant for six months afterwards ** Risks - sialadenitis, nasolacrimal duct obstruction, transient tumour/thyroid swelling, infertility, development of secondary malignancies (leukaemia)
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Adjuvant therapy for DTC
(section)
Add topic